Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexa Israeli

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
American Family Physician|January 14, 2022
Rapidly Progressive ErythrodermaSummer Moon, Alexa Israeli, Robert Daze
Cureus|January 11, 2024
Use of Interleukin-12/23 Inhibitor for the Management of Acne FulminansHannah Gier, Alexa Israeli, Austin Cusick, et al.
Cureus|July 22, 2024
Treatment of Recalcitrant Hailey-Hailey Disease With Naltrexone and Dupilumab: A Report of Two CasesBreanna Santoso, Rachel Krevh, Alexa Israeli, et al.
Journal of Drugs in Dermatology : JDD|August 2, 2024
Comparison of Characteristics Influencing Patient Selection of Sunscreen Between Urban and Rural Regions in the United StatesJoshua Burshtein, Danny Zakria, Milaan Shah, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
American Family Physician|January 14, 2022
Rapidly Progressive ErythrodermaSummer Moon, Alexa Israeli, Robert Daze
Cureus|January 11, 2024
Use of Interleukin-12/23 Inhibitor for the Management of Acne FulminansHannah Gier, Alexa Israeli, Austin Cusick, et al.
Cureus|July 22, 2024
Treatment of Recalcitrant Hailey-Hailey Disease With Naltrexone and Dupilumab: A Report of Two CasesBreanna Santoso, Rachel Krevh, Alexa Israeli, et al.
Journal of Drugs in Dermatology : JDD|August 2, 2024
Comparison of Characteristics Influencing Patient Selection of Sunscreen Between Urban and Rural Regions in the United StatesJoshua Burshtein, Danny Zakria, Milaan Shah, et al.
Pageof 1